English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Changes in the hepatitis C virus (HCV) viral load (VL) were assessed in a retrospective study of 50 HIV/HCV-coinfected patients who initiated highly active antiretroviral therapy (HAART). Most patients responded to HAART [during the first 6 months, plasma HIV VL fell by a mean 1.39 log 10 , becoming undetectable (&lt;400 copies/ml) in 22% and CD4+ T cells increased by a mean of 100 cells/μl], but surprisingly, 27 (54%) showed some rise and 25 (50%) showed a significant increase in the HCV VL. This figure was considered to be a minimum estimate. A majority of the patients showed an increase of less than 1 log 10  that was associated with a rapid decrease in the HIV VL, whereas an increase in the HCV VL of greater than 1 log 10 , noted in eight patients, was associated with a baseline CD4+ cell count of less than 200 cells/μl. The increase in the HCV VL was not associated with hepatitis as determined by raised alanine transferase.

antiviral therapy

A Study to Investigate the Impact of the Initiation of Highly Active Antiretroviral Therapy on the Hepatitis C Virus Viral Load in HIV/HCV-Coinfected Patients